A Look into Nucleic Acid Isolation And Purification Industry……Deep Analysis…..
The global nucleic acid
isolation and purification market
size is expected to reach USD 4.2
billion by 2027, growing at a CAGR of 7.2% during the forecast period,
according to a new report by Grand View Research, Inc. Nucleic acid isolation
is the most basic step deployed in sequencing technologies. Increasing
employment of next-generation sequencing (NGS) techniques along with the
declining cost of genomic sequencing drives the market.
Biopharmaceutical innovators are at the
forefront of the human response to the coronavirus pandemic. A significant
number of major biotech firms are in the midst of a race to investigate the
Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the
speed of response to SARS/MERs etc, the biotech entities are investigating
SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are
being put into the R&D. With multiple candidates in trial, the public and
private sectors are anticipated to work in unison for the foreseeable period,
until a vaccine is developed for Covid-19. The report will account for Covid19
as a key market contributor.
Ongoing developments of automated
nucleic acid extraction systems designed for high-throughput sample processing
have significantly simplified the isolation of DNA and RNA, thereby providing
lucrative avenues for market growth. These systems potentially reduce the labor
costs and time, increase worker safety, laboratory efficiency, reproducibility,
and quality of results.
The growing popularity of
biopharmaceuticals has led to the development of nucleic acid-based products,
such as DNA vaccines, small interfering RNA, and antisense oligonucleotides.
These products are applied in therapeutic techniques, such as gene therapy and
anti-sense technology, as a powerful tool for medical practitioners to treat
cancer, genetic, and infectious diseases. This has boosted the adoption of DNA
or RNA isolation techniques in the market.
To Request Sample Copy of this report, click the link:
Further key findings from the report suggest:
·
The instruments segment is
expected to grow at a lucrative pace due to the advent of automated extraction
systems resulting in high performance and lower cost for DNA extraction
·
DNA isolation methods accounted
for the largest revenue share and are anticipated to witness the fastest
progress rate due to ongoing discoveries of simple, rapid, and inexpensive
methods
·
The high adoption rate of
magnetic bead methods is attributive to its largest revenue share
·
This is because the method can
isolate nucleic acids directly from the crude sample without much processing
·
This method is also expected to
witness the fastest CAGR owing to the development of functionalized magnetic
particles that have been incorporated in buffer systems to provide rapid and
efficient extraction
·
Oncology application is
projected to witness a lucrative growth rate as liquid biopsy techniques and
patient-tailored therapies are gaining traction for cancer diagnosis
·
Hospitals and diagnostic
centers accounted for the largest share in 2020, in terms of revenue
·
The high incidence rate of
genetic and inherited diseases has increased the usage of nucleic acid
isolation in early and accurate diagnosis of these conditions in hospitals
·
Better healthcare
infrastructure, a substantial number of technology providers, and rapid
adoption of NGS has driven the uptake of nucleic acid extraction products in
North America at a large scale
·
Asia Pacific is anticipated to
exhibit the fastest CAGR over the forecast period owing to significant public
and private commitments towards genomics research and precision medicine,
thereby prompting the adoption of isolation techniques
·
QIAGEN, Agilent Technologies,
Danaher, Illumina, Roche, and Thermo Fisher are some key companies operating in
the nucleic acid isolation and purification market.
The global nucleic acid isolation and purification
market size was estimated at USD 2.4 billion in 2020 and is expected to
register a CAGR of 7.2% over the forecast period. Several RNA species represent
a wide, untapped class of biomolecules that play a vital role during disease
progression. This has enhanced the pipeline for RNA therapeutics, which in
turn, drives the application of nucleic acid isolation and purification
protocols for drug development.
The isolation of nucleic acid is one of the
essential achievements of modern science that brings advancement in human life.
A rise in the utilization of high-throughput and automated extraction
technologies has significantly simplified the DNA or RNA isolation processes.
Besides, the expansion of next-generation sequencing (NGS) technologies drives
the market for nucleic acid isolation and purification, because DNA and RNA
purification play a critical role in obtaining accurate NGS data.
Nucleic
acid-based diagnostics are extensively employed in laboratory settings to
diagnose a wide range of medical conditions. Increasing prevalence of cancer,
infectious diseases, genetic disorders, and neglected tropical diseases surge
the demand for isolation of DNA or RNA for the nucleic acid-based diagnostics,
hence providinghigh-value avenues in the market for nucleic acid isolation and
purification.
The
continuous advancements in agriculture science and technology have considerably
revolutionized the genetically modified (GM) crop production. The introduction
of multiple traits in GM crops through genetic engineering technologies provide
herbicide tolerance, drought tolerance, and insect resistance to crops. These
processes significantly increase the implementation of DNA extraction
procedures in GM crop production.
Browse Press
Release of this report:
Grand View Research has segmented the
global nucleic acid isolation and purification market on the basis of product,
type, method, application, end use:
Nucleic Acid Isolation And Purification Product Outlook
(Revenue, USD Million, 2016 - 2027)
·
Kits & Reagents
·
Instruments
Nucleic Acid Isolation And Purification Type Outlook
(Revenue, USD Million, 2016 - 2027)
·
DNA Isolation &
Purification
o Genomic DNA
o Plasmid DNA
o Viral DNA
o Other Types
·
RNA Isolation &
Purification
o miRNA
o mRNA
o Total RNA
o Other Types
Nucleic Acid Isolation And Purification Method Outlook
(Revenue, USD Million, 2016 - 2027)
·
Column-based
·
Magnetic Bead-based
·
Reagent-based
·
Other Methods
Nucleic Acid Isolation And Purification Application
Outlook (Revenue, USD Million, 2016 - 2027)
·
Oncology
·
Precision Medicine
·
Diagnostics
·
Drug Discovery &
Development
·
Agriculture and Animal Research
·
Other Applications
Nucleic Acid Isolation And Purification End-Use Outlook
(Revenue, USD Million, 2016 - 2027)
·
Academic Research Institutes
·
Pharmaceutical &
Biotechnology Companies
·
Contract Research Organizations
·
Hospitals and Diagnostic
Centers
·
Other End-use
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment